Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 828 across all filing types
Latest filing 2024-07-19 Capital/Financing Update
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Capital/Financing Update Classification · 1% confidence The document is titled "ADOCIA Announces Half year report on Adocia's liquidity agreement with Kepler Capital Markets" and provides specific figures regarding share counts and cash balances on June 30th, 2024, and December 31st, 2023. This content relates to the company's financial status and compliance with a liquidity agreement, which is a form of financial reporting for a specific period (half-year). Since it details the results for the first half of the year, it strongly suggests an Interim/Quarterly Report (IR). However, the document is structured as a press release announcing these figures, rather than the comprehensive financial statements typically found in a full Interim Report (IR) or Annual Report (10-K). It focuses narrowly on liquidity agreement activity and uses the structure of an Earnings Release (ER) or a specific regulatory update. Given the focus on half-year data and the format being a press release announcing specific financial metrics, it aligns best with an Interim Report (IR) if it were comprehensive, but as a brief announcement of key figures, it is closer to an Earnings Release (ER) or a specialized regulatory filing. Since it explicitly mentions the '1st half of 2024' and provides detailed figures for that period, it is a report on an interim period. If it were just the announcement of the full IR, it would be RPA/RNS. Because it contains the actual summarized financial data for the half-year period, it is classified as an Interim Report (IR).
2024-07-19 English
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information relative au nombre d'actions et de droits de vote en date du 30 Juin 2024" (Information relative to the number of shares and voting rights as of June 30, 2024). It explicitly states it is published in accordance with French commercial code (Code de Commerce) and AMF (Autorité des Marchés Financiers) regulations, detailing the total number of shares and voting rights (BRUT and NET) as of a specific date. This type of periodic disclosure regarding the capital structure and voting power is a standard regulatory requirement, often related to major shareholding notifications or capital structure updates. Since it is a formal announcement detailing the total share count and voting rights, it most closely aligns with a notification regarding capital structure changes or significant share ownership thresholds, although it is a routine monthly disclosure. Given the options, it is a specific regulatory disclosure. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a formal notification about the capital structure, which is often captured under general regulatory filings or specific share/capital change categories. Because it reports the total number of shares and voting rights, which is a key component of major shareholding notifications (MRQ) or general capital structure updates (SHA), and it is a formal regulatory announcement, I will check the definitions. It is not a Director's Dealing (DIRS) or a Dividend Notice (DIV). It is a mandatory disclosure of the total share count. This fits best under 'Major Shareholding Notification' (MRQ) as these reports often trigger or accompany threshold crossings, or 'Share Issue/Capital Change' (SHA) as it details the current capital base. However, the most precise fit for a routine monthly disclosure of total shares/voting rights under AMF rules is often categorized as a general regulatory filing or a specific capital structure update. Given the content is purely about the total share count and voting rights, it is a fundamental capital structure disclosure. I will classify it as 'Share Issue/Capital Change' (SHA) as it reports the current state of the capital base, or 'Regulatory Filings' (RNS) as a catch-all. Since it is a specific, recurring regulatory disclosure about the capital base, SHA is a strong candidate, but RNS is the fallback for specific regulatory announcements not covered elsewhere. Let's re-evaluate. This is a mandatory disclosure of the total number of shares and voting rights, which is often required when thresholds are crossed (MRQ) or as a routine update. Since it is a formal, specific regulatory announcement that doesn't fit the other specific financial reports, RNS (Regulatory Filings) is the safest general classification for mandatory, non-financial-statement regulatory updates in this context, although MRQ is also plausible if the context implies threshold reporting. Given the structure and content (a table of share counts mandated by AMF articles), RNS is the most appropriate general regulatory filing category when a more specific one like DIRS or DIV doesn't apply perfectly. However, since it directly reports the number of shares, SHA (Share Issue/Capital Change) is also highly relevant. I will lean towards RNS as it is a standard, periodic regulatory filing announcement that doesn't detail a transaction (POS) or a dividend (DIV). Upon review of similar filings, these monthly share capital disclosures are often classified as general regulatory announcements (RNS) unless they are explicitly tied to a specific transaction (SHA/POS) or threshold crossing (MRQ). I will use RNS as the general regulatory filing category for this mandatory AMF disclosure. The document length is over 5000 characters, so the RPA rule does not apply. Confidence is high due to clear regulatory context (AMF, L.233-8 II).
2024-07-11 French
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated July 11th, 2024, titled "Number of Shares and Voting Rights of ADOCIA as of June 30th, 2024." It explicitly states it is being released pursuant to French commercial code provisions and AMF (Autorité des Marchés Financiers) regulations (Article 223-16). The core content is a table detailing the total number of outstanding shares and voting rights as of a specific date (June 30, 2024). This type of mandatory disclosure regarding share capital structure and voting rights, often released monthly or quarterly, does not fit neatly into the primary financial report categories (10-K, IR, ER). It is a specific regulatory disclosure concerning capital structure changes or ownership reporting. While it relates to capital, it is not a financing announcement (CAP) or a share issue announcement (SHA) in the sense of raising funds or executing a buyback, but rather a periodic reporting of the current state of shares outstanding. This falls best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS), as it is a specific, mandated disclosure to the market regulator (AMF). It is not a Director's Dealing (DIRS) or Major Shareholding Notification (MRQ), as it reports the total outstanding shares, not individual transactions crossing thresholds.
2024-07-11 English
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is titled with an announcement: "ADOCIA Announces that Tonghua Dongbao is Discontinuing one of the two Partnership Programs...". It details a strategic decision by a partner to terminate a licensing agreement and discusses the immediate consequences, including the regaining of rights and the status of another project. It also announces a web conference to discuss the press release. This structure—a formal announcement of a significant business event (termination of a major licensing deal) followed by context and forward-looking statements—is characteristic of an Earnings Release (ER) or a general press release announcing material, non-financial news. Since it is not a full annual report (10-K), a quarterly report (IR), or a transcript (CT), and it focuses on a specific, material business event rather than just management commentary (MDA) or a general regulatory filing (RNS), the most appropriate classification is Earnings Release (ER), as these announcements often accompany or precede formal financial reporting periods, or serve as standalone material event disclosures. However, given the content is purely about a partnership termination and regaining rights, and it is structured as a formal press release, it could also be considered a Regulatory Filing (RNS) if it doesn't fit the strict definition of an ER (which usually focuses on financial results). Since it is a formal announcement of a material event, and the document length is substantial (7832 chars), it is more than just a brief notification. It functions as a primary disclosure of a significant corporate event. In many databases, such material event disclosures that are not explicitly financial results are often categorized as Regulatory Filings (RNS) or sometimes as a specific type of press release. Given the options, and noting it is a formal announcement of a corporate action, RNS is a strong candidate, but ER often covers material business updates outside of pure financial tables. Since it is a press release announcing a major corporate event (licensing termination) and includes a call for discussion, ER is often used for such material updates. Let's re-evaluate against the definitions. It is not an ER (which focuses on financial results highlights). It is not an MDA (Management's detailed explanation of financial results). It is a press release announcing a specific corporate action. This fits best under the general Regulatory Filings (RNS) category as a fallback for material announcements that don't fit the specific financial report types.
2024-07-10 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) dated July 10, 2024. It announces a specific corporate event: Tonghua Dongbao terminating one of two partnership programs (BioChaperone® Combo) with Adocia, and Adocia regaining full rights. It also mentions a scheduled web conference to discuss the release. This structure—a formal announcement of a significant business development (partnership change, clinical update, financial impact) released via a press release format—is characteristic of an Earnings Release (ER) or a general corporate update. Since it is not a full quarterly/annual report (IR/10-K) or a transcript (CT), and it details key financial/strategic impacts resulting from the event, 'ER' (Earnings Release) is the closest fit for a major, time-sensitive corporate announcement, even if it's not strictly tied to a standard quarterly reporting period. It functions as an immediate release of material information.
2024-07-10 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is explicitly titled a "PRESS RELEASE" announcing that Adocia will have three presentations at the American Diabetes Association (ADA) 84th Scientific Sessions. It details the content of these presentations (AdoShell®, AdOral®, AdoGel®) and provides specific presentation times and abstract numbers. This is not a full Annual Report (10-K), an Interim Report (IR), or a standalone Audit Report (AR). It is an announcement about scientific data being presented at a conference. While it contains scientific information, its primary function as a press release announcing participation in a scientific meeting aligns best with a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were the presentation itself. However, since it is a press release *announcing* presentations and data abstracts, and it doesn't fit the specific definitions for ER, MDA, or CT, RNS (Regulatory Filings/General Announcement) is the most appropriate general category for this type of corporate communication that isn't a core financial report or a specific management/governance document. Given the context of scientific data dissemination, it is a corporate announcement.
2024-06-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.